Browse the evidence

Depletion of Kupffer cells (liver macrophages) improves insulin signaling and hepatic insulin sensitivity in obese mice.

Targeting liver inflammation may be a viable strategy for improving insulin sensitivity, though current clinical applications of macrophage depletion are limited.

Inhibition of the Insulin/IGF-1 signaling (IIS) pathway extends lifespan by promoting the nuclear translocation of the DAF-16/FOXO transcription factor, which then activates downstream genes for stress resistance and longevity.

This research highlights that the body's insulin signaling system acts as a master switch for longevity. In model organisms, reducing the activity of this pathway (mimicking dietary restriction or stress) activates a specific transcription factor (FOXO/DAF-16) that moves to the cell nucleus to turn on protective genes. While this is a mechanistic finding in worms and mice, it suggests that metabolic health and insulin sensitivity are biologically linked to the aging process.

Orexin deficiency is the primary cause of narcolepsy, characterized by a loss of orexin-containing neurons in the lateral hypothalamus.

For individuals with narcolepsy, the underlying cause is often the loss of orexin-producing neurons. Treatments may focus on managing symptoms or potentially replacing orexin signaling, as the system is crucial for maintaining wakefulness.

Domestic economic development, urbanization, and women's empowerment drive global increases in BMI, whereas economic and cultural globalization do not significantly predict weight gain.

Focus on understanding how your country's economic development, urbanization, and social changes (like women's workforce participation) impact your community's health. Simply opening markets to global goods does not automatically cause obesity; domestic socio-economic transitions are the stronger drivers.

Exenatide treatment significantly reduces dopamine transporter (DAT) availability in the striatum, caudate, and putamen in patients with Alcohol Use Disorder.

Exenatide changes the brain's dopamine transporter levels in key reward areas, which may help compensate for the dopamine deficits seen in chronic alcohol use. This is a biological mechanism, not a direct measure of drinking behavior.

Epigenetic aging initiates early in life upon the loss of pluripotency during differentiation, and the epigenetic age of a tissue is largely determined by the composition of stem cells versus differentiated cells.

Epigenetic aging begins when cells lose their stem-like pluripotency and start differentiating. The overall epigenetic age of a tissue reflects the balance of young stem cells and older differentiated cells. Maintaining a healthy stem cell pool may help keep tissue-level epigenetic age lower.

Tight glucose control (targeting 4.4-6.1 mmol/L) increases mortality in critically ill patients compared to a less strict target (less than 10 mmol/L), and optimal targets may vary based on diabetes status.

Do not use tight glucose control (targeting 4.4-6.1 mmol/L) in critically ill patients. Instead, aim for a less strict target (less than 10 mmol/L) to avoid the increased mortality risk associated with tight control. Consider individualizing targets based on diabetes status.

Inhibition of mTORC1 by rapamycin extends lifespan in multiple species by enhancing autophagy and mitophagy, thereby maintaining mitochondrial homeostasis.

Rapamycin extends lifespan in model organisms by boosting cellular cleanup (autophagy/mitophagy). While effective, chronic use has side effects. Dietary restriction also activates this pathway, offering a natural way to achieve similar benefits without pharmaceutical intervention.

During early critical illness, intramuscular lipid delivery (from enteral or parenteral nutrition) is bioenergetically inert and does not contribute to ATP content or muscle mass preservation.

In the first week of critical illness, standard lipid-based nutrition does not appear to fuel muscle energy or prevent muscle loss because the muscle's mitochondria are dysfunctional. This suggests that early lipid delivery may be ineffective for muscle preservation in this specific acute phase.

Inhibition of sphingolipid synthesis (specifically via SPT inhibition by myriocin or CerS inhibition by fumonisin B1) extends lifespan in model organisms like yeast and C. elegans, suggesting that reducing ceramide production can delay aging.

Research in simple organisms shows that reducing the production of certain lipids (sphingolipids) can extend lifespan. This suggests that metabolic pathways involving lipid synthesis are key regulators of aging. For humans, this points to the importance of metabolic health and lipid balance, though direct application of inhibitors like myriocin is not currently a standard human intervention.

The novel rapamycin analog DL001 selectively inhibits mTORC1 in vivo without disrupting glucose or lipid homeostasis, unlike conventional rapamycin which causes metabolic side effects via mTORC2 inhibition.

This research identifies a specific compound (DL001) that inhibits the mTORC1 pathway without causing the metabolic side effects (like high blood sugar and bad cholesterol) seen with standard rapamycin. While promising for treating age-related diseases and tuberous sclerosis in future human trials, it is not currently available for general use. The key takeaway is that selective mTORC1 inhibition may be a viable strategy to avoid metabolic disruption.

DL001 effectively suppresses hyperactive mTORC1 signaling in cells lacking a functional TSC (Tuberous Sclerosis Complex), restoring normal gene expression.

DL001 is shown to be as effective as rapamycin in suppressing the overactive mTORC1 signaling found in Tuberous Sclerosis Complex (TSC) cells. This suggests DL001 could be a safer alternative for treating TSC, as it may avoid the metabolic side effects associated with current rapalog treatments, although this is currently limited to cell culture models.

Genetic overexpression of SIRT6 extends median and maximal lifespan in both male and female C57BL/6 mice by preserving hepatic gluconeogenesis and energy homeostasis during aging.

This research identifies SIRT6 as a key regulator of healthy aging in mice, specifically by maintaining the liver's ability to produce glucose (gluconeogenesis) from precursors like lactate and glycerol during fasting. This prevents the metabolic decline and frailty associated with aging. While this is a genetic model, it suggests that supporting metabolic flexibility and hepatic health may be crucial for longevity. For humans, this underscores the importance of maintaining metabolic health through regular physical activity and potentially time-restricted eating patterns that engage gluconeogenic pathways, rather than seeking a simple genetic fix.

In long-standing extensive alopecia areata (EAA), T-cells in the scalp exhibit a state of partial tolerance characterized by reduced production of IL-2 and IFN-gamma, resulting in a paucity of inflammatory change and preventing follicle destruction.

For those with long-standing hair loss, the issue may not be active inflammation to be fought, but a specific immune tolerance where T-cells stop producing key growth signals (IL-2) and inflammatory markers (IFN-gamma). This suggests treatments might need to address this specific 'tolerance' state rather than just suppressing general inflammation.

Long-term supplementation with 300 µg/day of selenium (as selenium-enriched yeast) in populations with moderately low baseline selenium status significantly increases all-cause mortality approximately 10 years after treatment cessation.

If you live in a region with low soil selenium (like parts of Europe), standard supplementation (100-200 µg/day) may be safe, but you should avoid high-dose supplements (300 µg/day or more) taken long-term. The study suggests that exceeding 300 µg/day of total selenium intake (diet + supplements) for 5+ years may increase your risk of death, particularly if you are under 65. Consult a doctor to check your baseline selenium levels before supplementing.

Cardiolipin oxidation is a primary event in the release of cytochrome c and increased permeability of the mitochondrial membrane to apoptosis factors.

Maintain mitochondrial health to prevent cardiolipin oxidation, which is a key step in apoptosis and aging.

Specific miRNAs (let-7e-5p, miR-210-3p) packaged in liver-derived EVs directly target Pgc1α in adipocytes to inhibit mitochondrial biogenesis and promote lipid accumulation.

This explains how liver signals suppress fat-burning (mitochondrial biogenesis) in fat cells. It suggests that high liver-to-fat signaling may contribute to obesity by actively suppressing fat oxidation.

Prophylactic administration of uPAR-targeting CAR T cells in young mice prevents the development of age-related metabolic dysfunction and maintains exercise capacity into old age.

Treating young organisms with senolytic CAR T cells can prevent metabolic decline and maintain physical fitness into old age. This suggests that early intervention might be more effective than late-stage treatment.

Prenatal exposure to tributyltin (TBT) permanently reprograms mesenchymal stem cells (MSCs) to favor adipogenesis over osteogenesis, leading to increased body fat and insulin resistance in offspring.

Avoid sources of tributyltin (TBT), such as contaminated seafood from areas with heavy marine shipping or old boat paint, and ensure home plumbing does not involve leaching organotins from PVC pipes, particularly for pregnant women.

Voluntary industry self-regulation and public-private partnerships are ineffective at reducing non-communicable disease (NCD) risk exposure and often serve to delay or prevent stricter statutory regulation.

Do not rely on voluntary industry pledges or 'healthy' marketing claims to manage NCD risk. These measures have been evaluated and found ineffective. Effective risk reduction requires statutory regulation, such as taxation, marketing restrictions, and clear labeling, enforced by public authorities rather than left to industry self-interest.

Mild depolarization of the inner mitochondrial membrane, mediated by mitochondria-bound hexokinases and creatine kinases, prevents the generation of mitochondrial reactive oxygen species (mROS) and is a crucial component of anti-aging mechanisms in long-lived mammals.

Longevity is linked to the ability of your cells to maintain 'mild depolarization' of mitochondria, a state where energy production is efficient enough to make ATP but low enough to prevent damaging ROS. This state is maintained by specific enzymes (hexokinases) bound to mitochondria. In short-lived animals, this mechanism fails with age, leading to oxidative damage. In long-lived animals, it persists. While you cannot directly 'dose' this mechanism, supporting mitochondrial health through exercise and metabolic flexibility may help preserve these kinase-mediated protective pathways.

The accumulation of senescent cells in tissues drives organ degeneration and aging phenotypes, and their clearance extends lifespan and improves homeostasis in mammalian models.

Focus on maintaining immune system health and reducing chronic stressors that induce senescence. While direct 'senolytic' interventions are emerging, lifestyle factors that reduce cellular stress (exercise, balanced nutrition) may help manage senescent cell burden.

Alternative splicing of the p53 gene produces the p44 variant, which accelerates aging phenotypes, cognitive decline, and senescence by hyperactivating the IGF-1 pathway.

Current research focuses on molecular mechanisms; no direct human intervention is recommended based solely on this paper.

Progeria (HGPS) is caused by a splicing mutation in the LMNA gene producing progerin, which sequesters in the nuclear membrane and reduces SIRT1 activity, modeling vascular aging.

Understanding progeria mechanisms aids research into normal vascular aging.